Clinical trial
Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given…
NCT00018967 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00018967 |
|---|---|
| Title | Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate |
| Official title | A Trial of Carboxypeptidase-G2 (CPDG2) For The Management of Patients With Intrathecal Methotrexate Overdose |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Children's Oncology Group |
| Status | Completed |
| Study type | Interventional |
| Conditions | Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor |
| Intervention type | Drug |
| Interventions | glucarpidase |
| Enrollment | 10 |
| Start date | Nov 1, 1993 |
| Primary completion | Apr 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 30, 2015 |
| Countries | Australia, Canada, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: